Molecular Targeted Therapy
7 clinical trials · Condition
◉ Watch Molecular Targeted Therapy
| Record | Firm | Date |
|---|---|---|
| Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma (NCT04521153) | Shanghai Zhongshan Hospital | 2021-03-25 |
| Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma (NCT04642547) | RenJi Hospital | 2020-12-02 |
| Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure (NCT04586088) | Sun Yat-sen University | 2020-05-05 |
| Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy (NCT01652560) | LiNanlin,Ph.D, Chief Physician,Clinical Professor | 2012-06-01 |
Track Molecular Targeted Therapy automatically
Every clearance here is in the API, with alerts when new ones post.